This inventor holds 1 USPTO granted patent. Top assignees: Korea Advanced Institute of Science and Technology, Korea University Research and Business Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,792 
1 out of 1,282 Years Active: 2026
Title: Phei Er Saw: Inventor in Biomarker and Nanodrug Delivery Research
Introduction
Phei Er Saw is an inventor associated with Guangdong, China. His patent work focuses on EDB-FN as a biomarker for cancer and/or brain disease and on a nanodrug delivery system targeting the same.
Latest Patents
The provided information lists one patent for Phei Er Saw: “EDB-FN as Biomarker of Cancer and/or Brain Disease and Nanodrug Delivery System Targeting Same.” This invention concerns the use of EDB-FN in disease identification and targeted drug delivery. The record lists 1 patent.
Career Highlights
Saw is associated with the Korea University Research and Business Foundation and the Korea Advanced Institute of Science and Technology. These organizations connect his listed patent work with academic and research institutions.
Collaborations
His listed coworkers include Kyuha Chong and Jungsul Lee. Their names are associated with the collaborative research reflected in the patent information provided.
Conclusion
Phei Er Saw’s listed invention brings together biomarker research and targeted nanodrug delivery, with institutional affiliations and collaborators spanning academic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile